Squarepoint’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-57,626
| Closed | -$196K | – | 2419 |
|
|
2018
Q3 | $196K | Buy |
+57,626
| New | +$196K | ﹤0.01% | 1777 |
|
|
2018
Q2 | – | Sell |
-66,812
| Closed | -$273K | – | 2215 |
|
|
2018
Q1 | $273K | Buy |
66,812
+42,664
| +177% | +$174K | ﹤0.01% | 1354 |
|
|
2017
Q4 | $112K | Sell |
24,148
-5,152
| -18% | -$23.9K | ﹤0.01% | 1927 |
|
|
2017
Q3 | $208K | Sell |
29,300
-9,011
| -24% | -$64K | ﹤0.01% | 1351 |
|
|
2017
Q2 | $277K | Buy |
38,311
+1,036
| +3% | +$7.49K | 0.01% | 1157 |
|
|
2017
Q1 | $230K | Sell |
37,275
-15,463
| -29% | -$95.4K | 0.01% | 1210 |
|
|
2016
Q4 | $309K | Buy |
+52,738
| New | +$309K | 0.01% | 1140 |
|
|
2016
Q3 | – | Sell |
-40,400
| Closed | -$267K | – | 1400 |
|
|
2016
Q2 | $267K | Sell |
40,400
-21,900
| -35% | -$145K | 0.02% | 786 |
|
|
2016
Q1 | $291K | Sell |
62,300
-17,851
| -22% | -$83.4K | 0.02% | 842 |
|
|
2015
Q4 | $405K | Buy |
+80,151
| New | +$405K | 0.04% | 649 |
|